For pricing please click 'Book your Appointment'

At Glo Clinic, anti-wrinkle treatments are personalised to your face, your movement and your goals. While many people use “Botox” as a catch-all term, there are several prescription-only options available in clinic, including Botox, Dysport, Xeomin, and Relfydess.

Each is a form of botulinum toxin type A, designed to temporarily relax targeted facial muscles and soften the appearance of lines caused by repeated expression. The difference between them lies in how quickly they take effect, how they diffuse, and how they feel once settled, allowing your clinician to choose the most suitable option for your individual anatomy and desired outcome.

We always begin with a comprehensive consultation, which is the most important part of the process. During this time, your clinician will assess your facial anatomy, muscle strength, and movement patterns, as well as your skin quality and symmetry. This allows for a highly tailored approach rather than a standardised treatment plan. Your goals are also discussed in detail, whether you’re looking for subtle softening, preventative treatment, or full-face balancing, so your results align with how you want to look and feel.

From there, a personalised treatment plan is created. This includes selecting the most appropriate product, mapping out precise injection points, and determining dosing based on your individual needs. You’ll also be guided through what to expect, including how long results take to develop, how long they typically last, and any potential side effects. This forms part of the informed consent process, ensuring you feel confident and well-informed before proceeding.

If treatment is undertaken on the same day, it is typically quick and minimally invasive, often taking around 10–15 minutes. There is little to no downtime, and most people return to normal activities shortly after. Results develop gradually over the following days, with full effects usually seen at around two to three weeks. Depending on the product used and individual factors, results generally last between three to five months. Patient results will vary. 

Book your appointment online.

Mandatory Statements: 

Relfydess prescription medicine contains 150 units of relabotulinumtoxinA for the treatment of frown lines and crow's feet around the eyes. Relfydess has risks and benefits. Ask your healthcare professional if Relfydess is right for you and to explain the possible side effects. Tell them if any side effects concern you. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. For details on precautions and side effects, see the Consumer Medicines Information at: www.measate.govt.nz. Unfunded for aesthetic indications. Product and treatment costs apply Galderma Australia PTY LTD NZBN 9429051812249, NZ Distributor: Healthcare Logistics, Auckland. NZ-REL-2600004. TAPS NP23980. January 2026.

Xeomin® (incobotulinum toxin ) Prescription Medicine for the treatment of upper facial lines: glabellar frown lines, crow’s feet round the eyes, horizontal forehead lines Xeomin has risks and benefits. Ask your doctor if Xeomin is right for you (incobotulinum toxin A, purified Botulinum toxin type A 50 Units and 100 Units For product information check with your doctor or Consumer Medicine Information on www.medsafe.govt.nz . Click for further details Merz, Sydney. Distributed by Healthcare Logistics, Auckland

Botox®, Prescription Medicine For the treatment of frown lines and crow’s feet round the eyes Botox® has risks and benefits. Ask your doctor if Botox is right for you Botulinum toxin type A 50, 100, 200 Units. For product information check with your doctor or Consumer Medicine Information on www.medsafe.govt.nz Click for further details. Allergan, Auckland.

Dysport® Prescription Medicine For the treatment of frown lines and crow’s feet round the eyes. Dysport® has risks and benefits. Ask your doctor if Dysport is right for you Botulinum toxin type A 300 or 500 Ipsen Units For product information check with your doctor or Consumer Medicine Information on www.medsafe.govt.nz . Click for further details Galderma, Auckland.

For pricing please click 'Book your Appointment'

Dermal fillers are a non-surgical treatment used to enhance facial features and restore lost volume. Made from hyaluronic acid (HA) a substance naturally found in the skin, they help replenish hydration and plumpness that decline with age as collagen and elastin levels decrease.

At Glo Clinic, we select the right type of filler based on your goals.

Thicker fillers are used to sculpt and restore structure in areas like the cheeks, chin and jawline.

Softer, more flexible fillers are ideal for delicate areas such as the lips, temples, under-eyes and hands. We also use ultra-soft fillers to smooth fine lines and wrinkles, including nasolabial folds, marionette lines, neck lines and the eye area.

Dermal filler is a medical procedure that require skill and precision. Poor technique can lead to complications such as vascular occlusion or unnatural results. Our experienced doctors and nurses are highly trained in safe injecting practices, facial anatomy and complication management. If needed, fillers can be dissolved using Hyalase to refine or reverse results.

Book your consultation online to discuss treatment options and create a bespoke plan for you.

Mandatory Statement - Dermal filler injections are Medical devices for the treatment of loss of volume in the skin. Dermal fillers have risks and benefits. Ask your doctor if dermal filler injections are is right for you. For further information ask your doctor or go to www.medsafe.govt.nz

For pricing please click 'Book your Appointment' - Take a look at our specials for our current deals.

Profhilo is a non-surgical injectable treatment designed to deeply hydrate the skin and improve overall skin quality. Made from one of the highest concentrations of pure hyaluronic acid (HA), it works by stimulating collagen and elastin production while attracting and retaining moisture within the skin.

Rather than adding volume or changing facial structure, Profhilo spreads beneath the skin to boost hydration, smooth fine lines, and improve firmness and elasticity. The result is a natural, radiant glow with healthier, more resilient skin.

Treatment involves a series of small injections at specific points, most commonly in the face, but it can also be used on the neck, décolletage, and hands. A course of two treatments, spaced about four weeks apart, is typically recommended for optimal results.

As with all injectable treatments, Profhilo requires a high level of skill and anatomical knowledge. Our experienced doctors and nurses are trained in precise placement and safe injecting techniques to ensure effective, natural-looking outcomes.

Book your appointment online.

Mandatory Statement: Profhilo® Medical Device Class III. For the redefinition and laxity remodelling where skin laxity is a problem. Profhilo has risks and benefits Contains low & high molecular weight hyaluronic acid (64mg /2ml) As your doctor if Profhilo is right for you For product information check with your doctor or from product details with the supplier Accelagen Pty Ltd. Whanganui

For pricing please click 'Book your Appointment' - Sunekos packages are available under Specials

Sunekos is a non-surgical injectable treatment designed to improve skin quality by stimulating collagen and elastin. It combines hyaluronic acid with a patented blend of amino acids to support the skin’s natural regeneration process, helping to restore firmness, elasticity, and hydration.

Unlike dermal fillers, Sunekos doesn’t add volume or alter facial structure. Instead, it works within the skin to smooth fine lines, improve texture, and brighten delicate areas, particularly under the eyes where traditional fillers may not be suitable.

Treatment involves a series of small injections just beneath the skin, commonly used on the face, under-eye area, neck, décolletage, and hands.

A course of treatments is typically recommended to achieve the best results, followed by maintenance as needed. We offer this as a package deal.

Mandatory Statement: SUNEKOS containing hyaluronic acid and amino acids is a class III medical device that modifies the structure of mature skin, restoring volume, filling wrinkles and folds in the skin and in scar sites. Sunekos has risks and benefits. Sunekos should not be used on patients: with known hypersensitivity to any of its components; presenting with a general infection, inflammation or irritation in the area to be treated; or in patients predisposed to coagulation disorders. A local reaction may rarely occur, caused by hypersensitisation phenomena, with symptoms that include oedema and sensation of burning and/or itching. These reactions normally resolve within two days. Consult your healthcare professional to see if Sunekos is right for you. For more information refer to the instructions for use. New Zealand Sponsor:AA- Med Pty LtdDistributed by:Xytide Biotech NZ Pty LTD

For pricing please click 'Book your Appointment'

Sculptra is a non-surgical injectable treatment designed to gradually restore facial volume and improve skin quality over time. Made from poly-L-lactic acid (PLLA), it works by stimulating your body’s own collagen production—helping to rebuild structure and support from within.

Unlike traditional dermal fillers, Sculptra doesn’t provide instant volume. Instead, results develop progressively as collagen is regenerated, creating a subtle, natural-looking improvement in firmness, thickness, and overall skin quality.

Sculptra is commonly used to treat areas of volume loss such as the cheeks, temples, jawline, and lower face, as well as improving skin laxity and texture. A series of treatments is typically recommended, with results continuing to improve over several months and lasting up to two years or more.

Book a consultation with our Doctors to discuss if Sculptra is right for you.

Mandatory Statement: Sculptra® Medical Device Class III to increase volume of depressed areas, particularly to correct skin depressions. Sculptra has risks and benefits. Contains Poly-L-Lactic acid implant suspension. Ask your doctor if Sculptra is right for you. For product information check with your doctor or from product details with the supplier. Click for further details. Galderma Australia Sydney. Distributed by Healthcare Logistics, Auckland.

For pricing please click 'Book your Appointment'

Radiesse is a non-surgical injectable treatment designed to restore volume while also stimulating your body’s natural collagen production. Made from calcium hydroxylapatite (CaHA) microspheres suspended in a gel, it provides an immediate lifting effect while supporting longer-term skin regeneration.

Unlike traditional hyaluronic acid fillers, Radiesse works in two ways, delivering instant structure and definition, then gradually encouraging collagen to improve skin firmness and quality over time.

Radiesse is commonly used to contour and restore areas such as the cheeks, jawline, and hands. It can also be diluted and used as a biostimulator to improve skin texture, elasticity, and overall skin quality in areas like the lower face, neck, and décolletage.

As with all injectable treatments, Radiesse requires a high level of skill and anatomical knowledge. Our experienced doctors and nurses are trained in advanced injecting techniques and safe practices to ensure natural-looking, balanced results.

Book a consultation with our Doctors online to discuss if Radiesse is right for you.

Radiesse - Radiesse® injectable implant is intended for plastic and reconstructive surgery, including deep dermal and sub-dermal soft tissue augmentation of the facial area and dorsum of the hands. Radiesse® injectable implant is indicated for: the treatment of nasolabial folds, marionette lines or jawline; the augmentation of cheeks; the hand augmentation to correct volume loss in the dorsum of the hands; and the restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus. Radiesse® (+) Lidocaine injectable implant is intended for plastic and reconstructive surgery, including deep dermal and sub-dermal soft tissue augmentation of the facial area and dorsum of the hands in adults. Radiesse® (+) Lidocaine injectable implant is indicated for: the treatment of nasolabial folds, marionette lines and jawline; the augmentation of cheeks; hand augmentation to correct volume loss in the dorsum of the hands; the restoration and/or correction of the signs of fat or volume loss (lipoatrophy) in the facial area and for rejuvenation of the hands fat loss (lipoatrophy) in people with human immunodeficiency virus. You should tell your practitioner and avoid treatment with Radiesse®/Radiesse® (+) Lidocaine if you: have had an allergic reaction to any of the ingredients or have severe allergies including anaphylaxis; if you tend to develop keloids or heavy scars; have any bleeding disorders, poor wound healing; inflamed or infected skin; are under the age of 18; are pregnant or breastfeeding. Please inform your practitioner of any diseases you have or have had. These include in particular cardiovascular diseases, autoimmune diseases, diabetes, tumors, skin infections or severe allergies. If you take medication or vitamins, have had previous cosmetic procedures, or have been treated with other implants, please inform your practitioner. Always read the label and consult your Healthcare Professional for more information. This medical device must be administered by a Healthcare Professional. Merz Australia Pty Ltd (ACN: 151 073 559) Sydney, Australia. NZ Distribution: Pharmacy Retailing NZ Limited t/a Health Care Logistics (HCL). 58 Richard Pearse Drive, Mangere, Auckland 2022. For more information please phone 0800 822 310.

For pricing please click 'Book your Appointment'

HArmonyCa is a hybrid injectable treatment designed to both lift and improve skin quality. It combines hyaluronic acid (HA) for immediate volume with calcium hydroxyapatite (CaHA) to stimulate collagen production over time, giving both instant and longer-lasting results.

Unlike traditional fillers, HArmonyCa works in two phases. The HA provides an immediate lifting and contouring effect, while the CaHA supports ongoing collagen regeneration, helping to improve skin firmness, elasticity, and overall structure.

HArmonyCa is commonly used to treat areas such as the cheeks, jawline, and lower face where both support and skin quality are key. Results are natural-looking, with gradual improvement continuing over time as collagen is rebuilt.

As a medical injectable, HArmonyCa requires advanced technique and a strong understanding of facial anatomy. Our experienced doctors and nurses are trained in safe injecting practices to deliver balanced, refined results tailored to your goals.

Book your consultation online.

Mandatory Statement : HArmonyCa™ Lidocaine is a medical device class III intended for professional use only. Composition: It is an injectable facial filler consisting of calcium hydroxyapatite microspheres (55.7%), cross-linked sodium hyaluronate gel (20mg/mL), phosphate buffer, and lidocaine hydrochloride (3mg/mL). Risks: It carries risks such as injection site swelling, bruising, redness, pain, tenderness, and itching. Actionable Statement: As a medical device, it is imperative that it is administered by a qualified, authorized medical practitioner. Adverse Event Reporting: Any adverse events must be reported to the supplier (Allergan Aesthetics, an AbbVie Company).

For pricing please click 'Book your Appointment'

At Glo Clinic, we understand the challenges of weight management, which is why we're excited to introduce our weight management programmes featuring Wegovy®, Saxenda®, Contrave® and Mounjaro.

These are all prescription-only medication, it’s essential to book an initial consultation with our doctors. During this consultation, our team will take a full medical history and conduct any necessary tests to determine which option is suitable for you.

Following your initial consultation, our team provides a comprehensive follow-up care to ensure your success. You’ll receive regular check-ins and adjustments to your weight management program, ensuring you're on track to reach your goals.

Mandatory statement:

Mounjaro® must be used in addition to a reduced-calorie diet and increased physical activity for persons living with obesity or overweight with at least 1 weight-related comorbid condition. In people with type 2 diabetes mellitus, Mounjaro® must be used in addition to diet and exercise, and may be used in addition to other medicinal products for the treatment of type 2 diabetes, at the discretion of a New Zealand registered doctor. Mounjaro® is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus. Mounjaro® is also indicated in additional to diet and exercise for chronic weight management, including weight loss and weight maintenance, in adults who meet certain body mass index (BMI) criteria. Mounjaro® contains the active ingredient tirzepatide and is available in the following dose forms: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. All KwikPens contain four once weekly 0.6 mL doses of Mounjaro®. Mounjaro® has risks and benefits. Ask your doctor if Mounjaro® is right for you. Use strictly as directed. If you experience side effects, see your doctor, pharmacist, or healthcare professional. The most common side effects of Mounjaro® are nausea, diarrhoea, vomiting, and constipation. Please refer to the Mounjaro® Consumer Medicine Information available at www.medsafe.govt.nz, or in your Mounjaro® KwikPen carton before taking your medicine. Mounjaro® is an unfunded prescription medicine – payment for this medicine and any additional doctor and pharmacy fees will be required. Eli Lilly, Auckland. © 2026 Eli Lilly and Company (NZ) Limited. MOUNJARO® and KwikPen® are registered trademarks of Eli Lilly and Company. Eli Lilly and Company (NZ) Limited. NZBN 9429039560643. PO Box 109197 Newmarket, Auckland 1149, New Zealand. Date of preparation: February 2026. CMAT-08263. TAPS MR12912. 2009414.

Saxenda ® is a prescription medicine that is unfunded - a prescription charge and doctor’s fees will apply. Saxenda ® is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial Body Mass Index of ≥30 kg/m2 (obese) or ≥27 kg/m2 to <30 kg/m2 (overweight) in the presence of at least one weight related comorbidity, such as dysglycaemia (pre-diabetes and type 2 diabetes mellitus), hypertension, dyslipidaemia or obstructive sleep apnoea. Saxenda ® contains liraglutide (rys) 6 mg/mL. Saxenda ® has risks and benefits. Ask your doctor if Saxenda ® is right for you. Use strictly as directed. If you experience side effects, see your doctor, pharmacist or healthcare professional. Very common side effects include nausea, vomiting, diarrhoea, constipation, headache. Please refer to the Saxenda ® Consumer Medicine Information available at www.medsafe.gov.nz, in your Saxenda ® pack or access this online atwww.novonordisk.co.nz/content/dam/ nncorp/nz/en/pdfs/leaflets/Saxenda ® cmi.pdf before taking your medication. Novo Nordisk Pharmaceuticals Ltd., G.S.T. 53 960 898.PO Box 51268 Pakuranga, Auckland, New Zealand. NovoCare. Customer Care Centre (NZ) 0800 733 737, novonordisk.co.nz PP1258

Wegovy® (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity, to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight and that may help adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight off. Wegovy® is a prescription medication. Ask your doctor if Wegovy® is is right for you. Use strictly as directed. If you experience side effects, see your doctor, pharmacist or healthcare professional. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Wegovy® FlexTouch® (semaglutide solution for injection). Available in the following dose forms: 0.25 mg (0.68 mg/mL), 0.5 mg (1.34 mg/mL), 1.0 mg (1.34 mg/mL), 1.7 mg (2.27 mg/mL) and 2.4 mg (3.2 mg/mL). Indication: As an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management (including weight loss and weight maintenance) in adult patients with an initial Body Mass Index (BMI) of ≥30 kg/m2 (obesity) or ≥27 kg/m2 to <30 kg/m2  (overweight) in the presence of at least one weight-related comorbidity; in adolescents ages 12 years and above with initial obesity* and body weight above 60 kg (* obesity (BMI ≥95th percentile) as defined on sex- and age-specific BMI growth charts (CDC.gov) – refer to full datasheet); as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with established cardiovascular disease, with a BMI ≥27 kg/m2, and without established Type 1 or Type 2 diabetes. Treatment with Wegovy® should be re-evaluated and discontinued if adolescent patients have not reduced their BMI by at least 5% after 12 weeks on the 2.4 mg or maximum tolerated dose. Dosage and administration: Administered subcutaneously once weekly at any time of day, with or without meals; starting dose 0.25 mg; increase to a maintenance dose of 2.4 mg over a 16-week period at 4 weekly intervals. In case of significant gastrointestinal symptoms, consider delaying dose escalation until symptoms have improved. If patients do not tolerate the 2.4 mg dose, the dose can be decreased to 1.7 mg weekly. Patients should re-escalate to the 2.4 mg dose if tolerated. Doses higher than 2.4 mg are not recommended. Must not be administered intravenously or intramuscularly. Contraindications:Hypersensitivity to semaglutide or any of its excipients. Warnings and precautions: Consider the risk of aspiration during general anaesthesia or deep sedation; dehydration in relation to gastrointestinal side effects in patients with impaired renal function may cause deterioration in renal function; there have been postmarketing reports of acute kidney injury and worsening of chronic renal failure. Inform patients of the characteristic symptoms of acute pancreatitis, and discontinue if suspected; do not restart if confirmed. Exercise caution in patients with a history of pancreatitis. Not studied in patients: treated with other products for weight management; with Type 1 diabetes; with congestive heart failure New York Heart Association (NYHA) class IV. Limited experience in patients: aged 85 years or more; with inflammatory bowel disease; with diabetic gastroparesis; with severe renal impairment; with severe hepatic impairment. Must not be used as a substitute for insulin. Should not be used in combination with other GLP-1 products. Treatment in combination with a sulfonylurea or insulin may have an increased risk of hypoglycaemia. The addition of Wegovy® in patients treated with insulin has not been evaluated. Patients with a history of diabetic retinopathy should be monitored for worsening. Not recommended for patients with uncontrolled or unstable diabetic retinopathy. When initiating treatment of semaglutide in patients treated with warfarin or other coumarin derivatives, frequent monitoring of INR is recommended. Pregnancy Category D. Not for use during pregnancy or breast-feeding. Interactions: Semaglutide delays gastric emptying, use with caution in patients receiving oral medicinal products that require rapid gastrointestinal absorption. Undesirable effects: Very Common (≥10%): nausea, vomiting, diarrhoea, constipation, abdominal pain, headache, fatigue. Common (≥1 to <10%): gastritis, gastroesophageal reflux disease, dyspepsia, eructation, flatulence, abdominal distension, dry mouth, dizziness, dysgeusia, dysaesthesia, cholelithiasis, hair loss, injection site reactions; in patients with Type 2 diabetes: hypoglycaemia, diabetic retinopathy. (April 2025)

Contrave® is an unfunded Prescription Medicine. CONTRAVE 8/90 (naltrexone hydrochloride and bupropion hydrochloride extended release tablets). CONTRAVE is indicated, as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients (≥18 years) with an initial Body Mass Index (BMI) of ≥ 30 kg/m2 (obese), or ≥ 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of one or more weight-related comorbidities (e.g., type 2 diabetes, dyslipidaemia, or controlled hypertension). Contrave has risks and benefits. Do not use in uncontrolled high blood pressure, a seizure disorder or a history of seizures, a tumour in the central nervous system, a history of bipolar disorder, patients currently dependent on chronic opioids or opiate agonists e.g. methadone or patients in acute opiate withdrawal, current or previous diagnosis of bulimia or anorexia, Pregnancy, concomitant administration of a monoamine oxidase inhibitor, severe liver or kidney disease. Precautions are possible thoughts of suicide, in controlled high blood pressure, concomitant administration with medicines that affect serotonin levels, possible likelihood of seizure and driving and operating machinery, history of mania or depression. Common side effects are nausea or vomiting, dizziness, dry mouth, constipation, headache. Ask your doctor if Contrave is right for you. Use strictly as directed. If symptoms persist or you have side effects, see your doctor. You will have to pay for this medicine as it is not funded on the Pharmaceutical Schedule. Normal doctor’s fees and pharmacy charges apply. Refer to the Consumer Medicine Information (CMI) at https://www.medsafe.govt.nz/consumers/cmi/c/contrave890.pdf for more detailed information. ©2025 Radiant Health, an iNova Pharmaceuticals company. Contrave is a registered trademark of iNova Pharmaceuticals. Distributed in New Zealand by Radiant Health Ltd, c/- Supply Chain Solutions, 74 Westney Road, Airport Oaks, Auckland. For all product enquiries: New Zealand Toll Free: 0508 375 394. TAPS NA 22069. NZ-2024-12-0013. Prepared January 2025.

For pricing please click 'Book your Appointment'

Skin cancer checks and mole removal are essential services focused on early detection, diagnosis, and treatment of suspicious skin lesions. Regular skin checks play a key role in identifying changes in moles or spots early, when treatment is most effective.

During a skin cancer check, your clinician will perform a thorough assessment of your skin using specialised tools to examine moles, freckles, and any areas of concern. We look for changes in size, shape, colour, and texture, as well as any new or unusual lesions.

If a mole or lesion requires removal, this can be performed safely in-clinic. Depending on the assessment, removal methods may include surgical excision or other appropriate techniques, with samples sent for histopathology if needed.

Skin cancer checks and mole removal are medical procedures that require clinical expertise and attention to detail. Our experienced doctors provide thorough assessments, clear guidance, and safe, effective treatment ensuring you feel informed and supported every step of the way.

Book your skin cancer check or cosmetic mole removal online.

For pricing please click 'Book your Appointment'

We understand that hormonal changes can impact how you feel day to day. Our Hormone Replacement Therapy (HRT) services are designed to support balance, wellbeing, and quality of life through a personalised, medical-led approach.

Our experienced clinicians take the time to understand your symptoms, health history, and goals, offering comprehensive assessments and tailored treatment plans where appropriate. We focus on safe, evidence-based care, with ongoing monitoring to ensure your treatment remains aligned with your needs over time.

Whether you’re navigating perimenopause, menopause, or other hormonal changes, our team provides a supportive and discreet environment where you can feel informed and confident in your care.

Book your consultation with our Doctors online.

For pricing please click 'Book your Appointment'

Salicylic and Glycolic chemical peels are professional skin treatments designed to exfoliate, refine, and refresh the skin. Using carefully selected acids, these peels work to remove dead skin cells, promote cell turnover, and improve overall skin clarity and texture.

Glycolic peels, derived from sugar cane, are ideal for brightening and smoothing the skin. They help to improve uneven tone, fine lines, and dullness by gently resurfacing the outer layers of the skin.

Salicylic peels are oil-soluble, making them particularly effective for congested or acne-prone skin. They work deep within the pores to reduce excess oil, clear blockages, and calm inflammation, helping to improve breakouts and overall skin clarity.

These treatments can be tailored to suit your skin type and concerns, with a course often recommended for optimal results. Over time, skin appears clearer, smoother, and more radiant.

As clinical treatments, chemical peels require professional assessment and application. Our experienced team will guide you on the most appropriate peel for your skin and ensure treatments are performed safely for the best possible outcome.

For pricing please click 'Book your Appointment'

Microneedling with NCTF is a non-surgical treatment designed to improve skin quality, hydration, and overall radiance. It combines advanced microneedling technology with NCTF—a revitalising cocktail of hyaluronic acid, vitamins, amino acids, and antioxidants, to nourish the skin from within.

Microneedling works by creating controlled micro-injuries in the skin, stimulating collagen and elastin production. At the same time, NCTF is delivered into the skin to boost hydration, support cellular repair, and enhance overall skin function. The result is smoother texture, improved tone, and a healthy, refreshed glow.

This treatment is ideal for addressing concerns such as fine lines, dullness, uneven skin texture, and early signs of ageing. It can be used on the face, neck, and décolletage, with a course of treatments typically recommended for optimal results.

As a clinical treatment, microneedling requires precision and expertise. Our experienced team uses medical-grade devices and tailored protocols to ensure safe, effective treatments with natural-looking results.

Mandatory Statement: NCTF 135 HA is a medical device used in aesthetic treatments. It must be administered by a qualified healthcare professional. Results may vary between individuals. A consultation is required to determine suitability. This product is not a prescription medicine. Use only as directed by your practitioner.

For pricing please click 'Book your Appointment'

IV Vitamin C infusions and NAD+ booster shots are wellness treatments designed to support overall vitality, energy, and skin health.

IV Vitamin C delivers a high concentration of vitamin C directly into the bloodstream via a drip, bypassing the digestive system for optimal absorption. Vitamin C is a powerful antioxidant that supports collagen production and helps protect the body from oxidative stress, leaving you feeling refreshed and revitalised.

NAD+ booster shots involve a quick intramuscular injection of nicotinamide adenine dinucleotide (NAD+), a coenzyme naturally found in the body that plays a key role in cellular energy production. As NAD+ levels decline with age, supplementation may support energy levels and overall wellbeing.

These treatments are administered by our trained medical team following a thorough consultation to ensure suitability. While many patients choose IV therapy and NAD+ as part of their wellness routine, results and experiences can vary from person to person.